Nanollose Ltd
ASX:NC6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nanollose Ltd
ASX:NC6
|
AU |
|
A
|
Axera Semiconductor Co Ltd
HKEX:600
|
CN |
|
I
|
Intuit Inc
XHAM:ITU
|
US |
|
Y
|
Yurtec Corp
TSE:1934
|
JP |
|
R
|
Rediff.com India Ltd
OTC:REDFY
|
IN |
|
E
|
EDP SA
F:EDP
|
PT |
|
S
|
SSE PLC
F:SCT
|
UK |
|
ProPetro Holding Corp
F:2PG
|
US |
|
Financiere de Tubize SA
F:FTD
|
BE |
|
Kits Eyecare Ltd
TSX:KITS
|
CA |
|
Anglogold Ashanti PLC
F:HT3
|
US |
|
HKE Holdings Ltd
HKEX:1726
|
HK |
|
A
|
Arabian Contracting Services Company SJSC
SAU:4071
|
SA |
|
ING Groep NV
NYSE:ING
|
NL |
|
Gunsynd PLC
LSE:GUN
|
UK |
|
D
|
DeepNoid Inc
KOSDAQ:315640
|
KR |
|
F
|
Fanuc Corp
SWB:FUC
|
JP |
|
Jupiter Marine International Holdings Inc
OTC:JMIH
|
US |
|
Invesco Ltd
NYSE:IVZ
|
US |
|
Eni SpA
LSE:0TD2
|
IT |
|
First Citizens BancShares Inc (Delaware)
NASDAQ:FCNCA
|
US |
Bankruptcy Probability
Nanollose Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Nanollose Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Nanollose Ltd
ASX:NC6
|
32.7m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
77.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Nanollose Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Nanollose Ltd has total debt of 250.2k AUD. This includes both short-term (250.2k AUD) and long-term (0 AUD) debt.
You can find a full breakdown on its Balance Sheet.